Free Trial

Zurich Insurance Group (ZURVY) Stock Forecast & Price Target

Zurich Insurance Group logo
$32.19 +0.08 (+0.25%)
As of 02/21/2025 03:59 PM Eastern

Zurich Insurance Group - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
2
Hold
1
Buy
1

Based on 4 Wall Street analysts who have issued ratings for Zurich Insurance Group in the last 12 months, the stock has a consensus rating of "Reduce." Out of the 4 analysts, 2 have given a sell rating, 1 has given a hold rating, and 1 has given a buy rating for ZURVY.

Consensus Price Target

N/A

Get the Latest News and Ratings for ZURVY and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Zurich Insurance Group and its competitors.

Sign Up

ZURVY Analyst Ratings Over Time

TypeCurrent Forecast
2/23/24 to 2/22/25
1 Month Ago
1/24/24 to 1/23/25
3 Months Ago
11/25/23 to 11/24/24
1 Year Ago
2/23/23 to 2/23/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
0 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
2 Hold rating(s)
Sell
2 Sell rating(s)
2 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price TargetN/AN/AN/AN/A
Forecasted UpsideN/AN/AN/AN/A
Consensus Rating
Reduce
Reduce
Hold
Reduce

ZURVY Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ZURVY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Zurich Insurance Group Stock vs. The Competition

TypeZurich Insurance GroupFinance CompaniesS&P 500
Consensus Rating Score
1.75
2.51
2.53
Consensus RatingReduceModerate BuyModerate Buy
Predicted UpsideN/A26.61% Upside14.37% Upside
News Sentiment Rating
Positive News

See Recent ZURVY News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
12/19/2024UBS Group
4 of 5 stars
W. Hardcastle
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeHold ➝ Strong Sell
10/3/2024BNP Paribas
3 of 5 stars
D. O'mahony
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeHold ➝ Strong Sell
9/18/2024The Goldman Sachs Group
2 of 5 stars
R. Department
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
5/17/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy
8/1/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageEqual Weight
7/7/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral
3/3/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOverweight ➝ Underweight

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 03:25 AM ET.


Should I Buy Zurich Insurance Group Stock? ZURVY Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Sunday, February 16, 2025. Please send any questions or comments about these Zurich Insurance Group pros and cons to contact@marketbeat.com.

Zurich Insurance Group
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Zurich Insurance Group AG:

  • The stock price recently traded at $31.33, which may present a buying opportunity for investors looking for value in the insurance sector.
  • There has been a significant decline in short interest, dropping 48.4% in January, indicating that fewer investors are betting against the stock, which can be a positive sign for potential growth.
  • Zurich Insurance Group AG has a strong presence in multiple regions, including Europe, North America, and Asia Pacific, which diversifies its revenue streams and reduces risk.
  • The company has a solid 200-day moving average of $32.83, suggesting that it has maintained a relatively stable price over the long term, which can be attractive for long-term investors.
  • Analysts have recently downgraded the stock to a "strong sell," which could lead to a potential rebound if the market overreacts, creating a buying opportunity for savvy investors.

Zurich Insurance Group
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Zurich Insurance Group AG for these reasons:

  • The recent downgrade by UBS Group from a "hold" to a "strong sell" rating raises concerns about the company's short-term performance and investor sentiment.
  • The stock has crossed below its 200-day moving average, which is often viewed as a bearish signal indicating potential further declines in stock price.
  • Despite a decline in short interest, the average daily trading volume remains relatively low, which can lead to increased volatility and risk for investors.
  • With a 12-month high of $32.04, the stock is currently trading closer to its low of $23.46, suggesting that it may not have strong upward momentum in the near term.
  • The company is facing competitive pressures in the insurance market, which could impact its profitability and growth prospects moving forward.

ZURVY Forecast - Frequently Asked Questions

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Zurich Insurance Group in the last year. There are currently 2 sell ratings, 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "reduce" ZURVY shares.

According to analysts, Zurich Insurance Group's stock has a predicted downside of -100.00% based on their 12-month stock forecasts.

Over the previous 90 days, Zurich Insurance Group's stock had 1 downgrade by analysts.

Zurich Insurance Group has been rated by research analysts at UBS Group in the past 90 days.

Analysts like Zurich Insurance Group less than other "finance" companies. The consensus rating for Zurich Insurance Group is Reduce while the average consensus rating for "finance" companies is Moderate Buy. Learn more on how ZURVY compares to other companies.


This page (OTCMKTS:ZURVY) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners